SEC Form 4 · accession 0001567619-19-005673
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Abdun-Nabi
Officer — CEO · Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 7:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2019 | F | 1,714 | $61.01 | D | 164,853 | D | |
| Common StockF1 | Feb 27, 2019 | F | 2,570 | $57.98 | D | 162,283 | D | |
| Common StockF1 | Feb 28, 2019 | F | 5,101 | $58.71 | D | 157,182 | D | |
| Common StockF2 | holding | — | — | — | 1,936 | I | By Son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
- F2The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.